Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | 1 | — | — | — | 1 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 1 | — | — | — | 1 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | — | — | — | 1 |
Drug common name | Tilarginine |
INN | tilarginine |
Description | N-Methylarginine is an inhibitor of nitric oxide synthase. Chemically, it is a methyl derivative of the amino acid arginine. It is used as a biochemical tool in the study of physiological role of nitric oxide.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | CNC(=N)NCCC[C@H](N)C(=O)O |
PDB | — |
CAS-ID | 17035-90-4 |
RxCUI | — |
ChEMBL ID | CHEMBL256147 |
ChEBI ID | 28229 |
PubChem CID | 4366 |
DrugBank | — |
UNII ID | 27JT06E6GR (ChemIDplus, GSRS) |